Investor Type
Ning Li is the CEO of Shanghai Junshi Biosciences.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Coherus Biosciences | Shanghai Junshi Biosciences | Post-IPO Equity - Coherus Biosciences | obfuscated obfuscation | |
obfuscated obfuscation | IMPACT Therapeutics | Shanghai Junshi Biosciences | Series C - IMPACT Therapeutics | obfuscated obfuscation |